Published by Iain Gilbert on 10th August 2020
(Sharecast News) - Pharmaceutical services company Open Orphan has scored a £4.0m contract with an unnamed top-three global pharmaceutical company to be the sponsor of and provide a respiratory syncytial virus human challenge study trial.
URL: http://www.digitallook.com/dl/news/story/31034991/...